AMI-1

Catalog No.S7884 Batch:S788401

Print

Technical Data

Formula

C21H14N2Na2O9S2
Molecular Weight 548.45 CAS No. 20324-87-2
Solubility (25°C)* In vitro DMSO 100 mg/mL (182.33 mM)
Water 22 mg/mL (40.11 mM)
Ethanol Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description AMI-1 is a potent and specific Histone Methyltransferase (HMT) inhibitor with IC50 of 3.0 μM and 8.8 μM for yeast Hmt1p and human PRMT1, respectively.
Targets
yeast Hmt1p [1]
(Cell-free assay)		 human PRMT1 [1]
(Cell-free assay)
3.0 μM 8.8 μM
In vitro In HeLa cells, AMI-1 inhibits methylation levels of GFP-Npl3 fusion and endogenous PRMT1-like activity. AMI-1 also inhibits nuclear receptor-mediated transactivation of a luciferase reporter in MCF7 cells. [1] In addition, AMI-1 inhibits HIV-1 RT polymerase activity with IC50 of 5 μM and inhibits DNA binding to HIV-1 RT with Kd of 2 μM. [2] In INS-1 cells, AMI-1 improves INS-1 cell function and mediates translocations of FOXO1 and PDX-1 intracellularly by regulating FOXO1 phosphorylation and methylation. [4]
In vivo In chronic AIPI rats, AMI-1 (5 μg/rat) ameliorates COX2 expression and asthmatic indexes, and decreases the airway and alveoli lesions, mucus secretion, and collagen deposition in lungs. [3]

Protocol (from reference)

Animal Study:[3]
  • Animal Models

    Chronic AIPI rats

  • Dosages

    50 μL at a concentration of 0.1 mg/mL

  • Administration

    Intranasal injection

Customer Product Validation

Data from [Data independently produced by , , Nitric Oxide, 2017, 1-10]

Selleck's AMI-1 has been cited by 7 publications

PRMT1 reverts the immune escape of necroptotic colon cancer through RIP3 methylation [ Cell Death Dis, 2023, 14(4):233] PubMed: 37005412
Methylation of HBP1 by PRMT1 promotes tumor progression by regulating actin cytoskeleton remodeling [ Oncogenesis, 2022, 11(1):45] PubMed: 35941115
PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer [ Oncogene, 2021, 40(7):1375-1389] PubMed: 33420374
PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer [ Oncogene, 2021, 10.1038/s41388-020-01617-0] PubMed: 33420374
Hypoxia stimulates SUMOylation-dependent stabilization of KDM5B [ Research Square, 2021, 10.21203/rs.3.rs-620216/v1] PubMed: None
CARM1 Methylates GAPDH to Regulate Glucose Metabolism and Is Suppressed in Liver Cancer. [ Cell Rep, 2018, 24(12):3207-3223] PubMed: 30232003
The asymmetric dimethylarginine-mediated inhibition of nitric oxide in the rostral ventrolateral medulla contributes to regulation of blood pressure in hypertensive rats. [Tan X, et al. Nitric Oxide, 2017, 67:58-67] PubMed: 28392446

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.